Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autoantibodies in hospitalised patients with COVID-19.
Tiniakou E, Casciola-Rosen L, Thomas MA, Manabe Y, Antar AA, Damarla M, Hassoun PM, Gao L, Wang Z, Zeger S, Rosen A. Tiniakou E, et al. Clin Transl Immunology. 2024 Dec 26;13(12):e70019. doi: 10.1002/cti2.70019. eCollection 2024. Clin Transl Immunology. 2024. PMID: 39734590 Free PMC article.
Association of Anti-CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti-Transcriptional Intermediary Factor 1γ-Positive Dermatomyositis.
Fiorentino D, Mecoli CA, Igusa T, Albayda J, Paik JJ, Tiniakou E, Adler B, Mammen AL, Shah AA, Rosen A, Christopher-Stine L, Casciola-Rosen L. Fiorentino D, et al. Among authors: tiniakou e. Arthritis Rheumatol. 2023 Jul;75(7):1238-1245. doi: 10.1002/art.42474. Epub 2023 May 9. Arthritis Rheumatol. 2023. PMID: 36762496 Free PMC article.
The Relationship Between Anti-Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti-Sp4 Autoantibodies, and Cancer in Anti-Transcription Intermediary Factor 1γ-Positive Dermatomyositis.
Mecoli CA, Fiorentino D, Albayda J, Paik JJ, Tiniakou E, Adler B, Mammen AL, Christopher-Stine L, Rosen A, Casciola-Rosen L. Mecoli CA, et al. Among authors: tiniakou e. ACR Open Rheumatol. 2024 Dec;6(12):912-917. doi: 10.1002/acr2.11750. Epub 2024 Oct 6. ACR Open Rheumatol. 2024. PMID: 39370373 Free PMC article.
Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.
Casal-Dominguez M, Pinal-Fernandez I, Corse AM, Paik J, Albayda J, Casciola-Rosen L, Johnson C, Danoff SK, Christopher-Stine L, Tiniakou E, Mammen AL. Casal-Dominguez M, et al. Among authors: tiniakou e. Neurology. 2019 Mar 26;92(13):e1416-e1426. doi: 10.1212/WNL.0000000000007188. Epub 2019 Mar 1. Neurology. 2019. PMID: 30824556 Free PMC article.
Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies.
Casal-Dominguez M, Pinal-Fernandez I, Pak K, Huang W, Selva-O'Callaghan A, Albayda J, Casciola-Rosen L, Paik JJ, Tiniakou E, Mecoli CA, Lloyd TE, Danoff SK, Christopher-Stine L, Mammen AL. Casal-Dominguez M, et al. Among authors: tiniakou e. Arthritis Rheumatol. 2022 Mar;74(3):508-517. doi: 10.1002/art.41964. Epub 2022 Feb 1. Arthritis Rheumatol. 2022. PMID: 34480833 Free PMC article.
Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population.
Mecoli CA, Igusa T, Chen M, Wang X, Albayda J, Paik JJ, Tiniakou E, Adler B, Richardson C, Kelly W, Danoff S, Mammen AL, Platz EA, Rosen A, Christopher-Stine L, Casciola-Rosen L, Shah AA. Mecoli CA, et al. Among authors: tiniakou e. Arthritis Rheumatol. 2023 Apr;75(4):620-629. doi: 10.1002/art.42311. Epub 2023 Feb 16. Arthritis Rheumatol. 2023. PMID: 35878018 Free PMC article.
59 results